94 Does a pharmacist care management program improve hypertension outcomes in Veterans?

Tuesday, October 23, 2012: 10:35 AM
Westin Diplomat Resort
Alan J. Zillich, PharmD1, Heather A. Jaynes, RN, MSN1, Susan D. Bex, PharmD, BCPS2, Amy S. Boldt, PharmD2, Darin C. Ramsey, PharmD2, Cassandra M. Walston, PharmD2 and Dawn M. Bravata, MD2
1Purdue University College of Pharmacy, Indianapolis, IN
2Richard L. Roudebush VA Medical Center, Indianapolis, IN

Purpose: To evaluate a care management program for Veterans with hypertension (HTN) provided by clinical pharmacists.

Methods: Using a retrospective case-control design, cases included all HTN patients referred to the care management program while controls included HTN patients who were not referred to the program during the same one-year period. Each case was matched to a maximum of three controls on: primary care physician, age±5 years, diagnoses of diabetes and kidney disease, baseline systolic blood pressure(SBP) ±10 mmHg, and number of unique BP medications. Primary outcomes were SBP and diastolic blood pressure(DBP) at 6-,9-, and 12-months follow-up from baseline. Multivariate regression models compared each BP endpoint between the cases and controls adjusting for age, co-morbidities, baseline BP and baseline number of BP medications.  Similar logistic regression models evaluated national guideline-defined BP control.

Results: Three to one matching was achieved in 77.4%(418/540) of cases; 85%(460/540) of cases had at least one matched control. Cases and controls did not differ with respect to age, gender, or co-morbidity; baseline BP was higher (139.6/80.0 vs. 136.7/78.2 mmHg) and BP control lower (35% vs. 49%) in the cases compared to controls. Among cases(n=460), BP decreased from baseline by -5.3/-2.4, -7.7/-3.2, and -6.6/-3.0 mmHg at 6-,9-, and 12-months; BP decreased among controls(n=1264) by -2.0/-1.0, -1.9/-0.9, and -3.4/-1.6 mmHg at 6-,9-, and 12-months.  Multivariate regression modeling results identified significantly lower SBP for the cases compared with controls at all time points; but for DBP, only the 9-month follow-up was significantly lower. BP control was better among cases than controls at 6-(56% vs. 55%;OR=1.8 CI:1.3-2.4; p<0.001) and 9-months(65% vs. 54%;OR=2.3 CI:1.7-3.0; p<0.001) but not at 12-months(57% vs. 60%;OR=1.3 CI:0.95-1.7; p=0.11).

Conclusion: Patients referred to the pharmacist hypertension care management program had a significant improvement in most BP outcomes.  This program may be an effective method of improving BP control among Veterans.